# SQZ Biotechnologies Company (SQZB)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/SQZB/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2023 | $ 192.5K | $ -62.82M | $ -58.05M | $ 21.47M | $ 1.88M |
| 2022 | $ 23.99M | $ -88.77M | $ -93.92M | $ 27.47M | $ 57.15M |
| 2021 | $ 20.33M | $ -40.74M | $ -49.93M | $ 69.69M | $ 123.98M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 11.42 |
| Liabilities / Eq | 14.84 |
| Current Ratio | 1.37 |

## Other views

- [Metrics](https://sponda.capital/en/SQZB.md)
- [Charts](https://sponda.capital/en/SQZB/charts.md)
- [Compare](https://sponda.capital/en/SQZB/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.